GRI BIOPAR |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4451 USD | +3.51% |
|
-18.55% | -93.36% |
| Apr. 16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
| 2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.640 | 3.370 | 3.198 |
| Spread/Res. | -83.14% | -86.79% | -86.08% |
| Spread/Supp. | +27.17% | +27.17% | +47.87% |
| Support | 0.3500 | 0.3500 | 0.3010 |
- Stock Market
- Equities
- GRI Stock
- Charts GRI BIOPAR
